NewsRoom Articles - Page 38 of 612

ThursdayJan 02, 2025 4:20 pm

420 with CNW — Could the Growing Popularity of THC Drinks Push Alcohol Out of the US Market?

New laws in the United States are making it possible to include THC in beverages, offering what some see as a potential alcohol alternative. While this development is being met with optimism by some, others believe its benefits may vary. Policies enabling the sale of THC-infused drinks are becoming more common, often placing them in venues that sell alcohol. Minnesota, for instance, passed legislation last year permitting the sale of THC beverages in liquor establishments, and these products have since started appearing across the country. The 2018 Farm Bill included a loophole that lifted federal prohibitions on hemp-derived products with…

ThursdayJan 02, 2025 10:00 am

What 2025 Could Hold for Marijuana Firms

The past couple of years have been rough on America's state-level cannabis industry. Cannabis businesses enjoyed healthy demand during the COVID-19 pandemic, particularly in states where cannabis was deemed an essential product, but the industry has been plagued with market oversaturation, low prices, and increasing black market competition in the years since. Investors have been especially wary of putting their funds into the industry, even with a Democratic president at the helm, and could be even more unwilling to invest in the sector under a second Trump presidency. The period of post-pandemic purchasing that was characterized by unusually high demand…

MondayDec 30, 2024 4:20 pm

420 with CNW — Study Explores the Ethical Complexities Linked to Undertaking Marijuana Research Funded by Industry Actors

Researchers from the Center for Addiction and Mental Health (CAMH) are exploring the ethical implications of marijuana research that's largely funded by actors with industry interests. Prior to the recent wave of state-level legalization, studying the potential risks and benefits of marijuana was practically impossible, making the recent rush of cannabis-related studies even more important for the fledgling cannabis market. These studies give us a glimpse into marijuana and how its use affects humans, particularly in the long term. However, a lot of cannabis research is conducted by actors who stand to make financial gains if the research yields positive…

FridayDec 27, 2024 4:20 pm

420 with CNW — Survey Suggests Most American Teens Are Shunning Alcohol, Tobacco, and Marijuana

Drug use in teenagers has not returned to pre-pandemic levels, according to findings from a recent survey. This year, nearly two-thirds of high school seniors reported abstaining from e-cigarettes, cannabis, alcohol, or cigarettes over the past month. This marks the highest abstinence rate since the annual nationwide survey began tracking this data in 2017. Additionally, 80% of students in grade 10 said they had not used any of these substances recently, setting another record. Ninety percent of those in grade 8 said they did not use any of the substances, which is the same percentage as in the prior study.…

FridayDec 27, 2024 10:00 am

Foreign Companies Could Tap into Germany’s Marijuana Pilot Programs

Non-German companies could potentially benefit from new recreational marijuana pilot programs in Germany, observers say. The European nation partially decriminalized adult-use cannabis on April 1, 2024, becoming the 9th country in the world to legalize cannabis and granting millions of Germans access to the drug. Interestingly, Germany's recreational cannabis measures also allow foreign companies to enter the German market via a cannabis pilot program license. These entities would need approval from the German municipality where they would set up shop. Furthermore, they have to prove that their pilot program had a scientific or experimental component to receive a pilot program…

FridayDec 27, 2024 9:21 am

WEED Inc. President and CEO Releases Letter to Shareholders

TUCSON, Ariz., Dec. 27, 2024 (GLOBE NEWSWIRE) — via IBN – WEED Inc. (OTCQB: BUDZ), (“WEED,” “HEMP” or the “Company”), a global cannabis and hemp bioresearch company based in the U.S., shares the Company’s 2025 plans and reviews its 2024 highlights in a letter to shareholders. Dear Fellow Shareholders, WEED Inc. is a global cannabis and hemp bioresearch company based in the USA, focused on the development and application of cannabis–derived compounds for the treatment of human and animal diseases, and is pleased to announce today that we intend to expand into “consumer packaged goods” utilizing our rare Landrace strains including…

ThursdayDec 26, 2024 4:20 pm

420 with CNW — South Carolina Legislator Files Bill to Legalize Medical Marijuana

A senator in South Carolina has proposed a measure aimed at legalizing medical marijuana for individuals suffering from certain medical conditions. The measure was pre-filed by Senator Tom Davis (R) in preparation for next year’s legislative session. The legislation closely mirrors earlier legislation introduced by Davis that gained approval in the state Senate earlier in the year but failed to progress in the House of Representatives. If passed, it would allow patients diagnosed with specific debilitating or terminal conditions to access medical marijuana. Conditions covered under the bill include Crohn’s disease, cancer, multiple sclerosis, epilepsy, PTSD, and terminal illnesses where…

ThursdayDec 26, 2024 10:00 am

Recent Scientific Findings Altering Our Knowledge about Marijuana

While around one in every five Americans now use marijuana, the understanding of its health effects has historically been limited. However, as regulations surrounding cannabis ease, scientists are gaining new insights into its benefits and risks. Many believe it’s a safe and natural option for managing pain, muscle spasms, nausea, appetite issues, and PTSD. While research supports this, cannabis isn’t as risk-free as some assume. With fewer barriers to conducting research on the drug, scientists are uncovering potential long-term impacts on mental health, the lungs, the digestive system, and the heart. Still, much remains unknown due to limited studies. Let’s…

MondayDec 23, 2024 4:20 pm

420 with CNW — New York Marijuana Firms Call for Tax Reforms as They Struggle to Survive

New York marijuana cultivators and processors are pushing Governor Kathy Hochul to approve a measure that would simplify how they handle tax filings, switching the system to an annual basis. Currently, businesses are required to pay a 9% marijuana excise tax on wholesale prices every quarter. The change would be a minor adjustment to existing regulations but one that could offer significant relief to those struggling in an already challenging market, according to Jaunty co-founder and CEO Nick Guarino. Companies like Jaunty, alongside Ayrloom and Alliance, collaborated with Park Strategies to draft the measure, receiving support from Assemblywoman Donna Lupardo…

FridayDec 20, 2024 4:20 pm

420 with CNW — DEA Requests Judge to Compel FDA Officials to Testify During Cannabis Reclassification Hearings

The DEA is requesting approval from an agency judge to issue subpoenas compelling officials from the FDA to testify at forthcoming hearings regarding the Biden administration’s proposal to reschedule cannabis. Friday was the deadline for parties involved in the hearing to submit additional materials, including evidence and witness information, to DEA Judge John Mulrooney as part of the pre-hearing process. The DEA stated in its filing that it plans to subpoena four FDA officials, even though the HHS previously stated that it wouldn’t voluntarily participate in the proceedings. Additionally, the DEA announced its intention to introduce thousands of comments from…